Synsam AB (publ) (SYNSAM.ST)
SEK 45.3
(2.37%)
SEK 45.3
(2.37%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2023 | 707 Million SEK | 18.43% |
| 2022 | 597 Million SEK | 32.37% |
| 2021 | 451 Million SEK | 17.63% |
| 2020 | 383.4 Million SEK | 13.47% |
| 2019 | 337.9 Million SEK | 13.62% |
| 2018 | 297.4 Million SEK | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 784 Million SEK | 1.42% |
| 2024 Q1 | 773 Million SEK | 9.34% |
| 2023 Q4 | 707 Million SEK | -1.67% |
| 2023 Q2 | 705 Million SEK | 4.29% |
| 2023 Q1 | 676 Million SEK | 13.23% |
| 2023 Q3 | 719 Million SEK | 1.99% |
| 2023 FY | 707 Million SEK | 18.43% |
| 2022 Q4 | 597 Million SEK | 0.34% |
| 2022 FY | 597 Million SEK | 32.37% |
| 2022 Q3 | 595 Million SEK | 6.82% |
| 2022 Q2 | 557 Million SEK | 3.72% |
| 2022 Q1 | 537 Million SEK | 19.07% |
| 2021 Q1 | 435 Million SEK | 13.58% |
| 2021 Q4 | 451 Million SEK | 1.58% |
| 2021 Q3 | 444 Million SEK | 1.6% |
| 2021 Q2 | 437 Million SEK | 0.46% |
| 2021 FY | 451 Million SEK | 17.63% |
| 2020 FY | 383.4 Million SEK | 13.47% |
| 2020 Q4 | 383 Million SEK | 0.0% |
| 2020 Q1 | - SEK | 0.0% |
| 2019 FY | 337.9 Million SEK | 13.62% |
| 2018 FY | 297.4 Million SEK | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| AddLife AB (publ) | 1.65 Billion SEK | 57.229% |
| Biotage AB (publ) | 437 Million SEK | -61.785% |
| Bonesupport Holding AB (publ) | 83.3 Million SEK | -748.699% |
| Doxa AB (publ) | - SEK | -Infinity% |
| Elekta AB (publ) | 3.25 Billion SEK | 78.306% |
| iZafe Group AB (publ) | 4.05 Million SEK | -17348.178% |
| Ortivus AB (publ) | 12.45 Million SEK | -5574.613% |
| Ortivus AB (publ) | 12.45 Million SEK | -5574.613% |
| Q-linea AB (publ) | 46.52 Million SEK | -1419.548% |
| S2Medical AB (publ) | 4.09 Million SEK | -17145.118% |